X. Kong

Design and Discovery of Quinazoline- and Thiourea-Containing Sorafenib Analogs as EGFR and VEGFR-2 Dual TK Inhibitors

F. Fu, Jingwen Zhang, Ningning Wang, 2017, Molecules.

Design, synthesis and biological evaluation of thiourea and nicotinamide-containing sorafenib analogs as antitumor agents

Wenfang Xu, Jianwen Yao, X. Kong, 2015 .

Synthesis of a newly designed artificial antigen and preparation of a polyclonal antibody against salbutamol

X. Kong, B. Huai, Xianhui Huang, 2014 .

Identification and elucidation of the structure of in vivo metabolites of diaveridine in chicken.

B. Yuan, Limin He, Z. Zeng, 2014, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Research Progress in Synthesis of Indole Alkaloids Vindoline and Vindorosine

Hongbin Zhang, X. Kong, Yipeng Zhang, 2022, Chinese Journal of Organic Chemistry.

Monitoring inflammation-cancer progression by cell viscosity, polarity and leucine aminopeptidase using multicolor fluorescent probe

Haiyan Chen, Zhenwei Yuan, Yue Xu, 2022, Chemical Engineering Journal.

Design and discovery of thioether and nicotinamide containing sorafenib analogues as multikinase inhibitors targeting B-Raf, B-RafV600E and VEGFR-2.

Ningning Wang, Jianwen Yao, X. Kong, 2018, Bioorganic & medicinal chemistry.

Synthesis of affinity column of phosphatidylinositol‐3,4‐diphosphate

X. Kong, T. Ogasawara, Ozaki Shoichiro, 2010 .